top of page
NOmoreFEARnz: Video
84770f_b099eedde9be410db099b96ed6b48779mv2.webp

The time has come for everyone living with Type 1 diabetes in Aotearoa, New Zealand to stop living in fear.

Type 1 diabetes is a life threatening autoimmune condition that anyone can develop at any time.

There is no known cause and no known cure for Type 1 diabetes.  However, there is a solution to prevent individuals with Type 1 diabetes living in fear

Act and help us by signing this petition to fund all CGM for those living with TYP1 Diabetes ...

NOmoreFEARnz: About
trans_1000x1000.png
LOGO_FINAL_slant_trans_square+.png
trans_1000x1000.png
NOmoreFEARnz: Team Members

Hard Truth

NOmoreFEARnz: Text

A CGM device is life saving

Approximately 1 in 500 school aged children have been diagnosed as living with Type-1 diabetes in New Zealand.

Enabling access to fully funded Continuous Glucose Monitors (CGM) would allow families to live without fear regardless of what socio economic background they come from 

*Source -Ministry of Health.

Current cost to NZ $40 Million
(2018-2022)

The total cost of hospital admissions for Type-1 Diabetics (between 2018-2022 in New Zealand Public Hospitals) totaled more than $40,000,000.

CGM would reduce that cost

*Source -Ministry of Health.

How can you help?

Sign our petition calling the government to fund Continuous Glucose  Monitoring devices for all those living with Type-1 Diabetes in New Zealand.


Share the petition with every person you know.

Talk to your local MP

*Source -Ministry of Health.

NOmoreFEARnz: Services
NOmoreFEARnz: News
Landscape 2 _edited_edited_edited.jpg

"I don’t want Kepaleli to be known as ‘the diabetic’, he’s a child with diabetes, and he will have to learn how to manage this for the rest of his life.. "

Dame Valerie Adams

opinions-change.org_.jpg

Sign the petition

Act Now, sign the petition at the Change.org website

NOmoreFEARnz: Welcome

Contact Us

Lavina Good

#NOmoreFEAR

0800 NOmoreFEAR

  • Facebook
  • Instagram

Thanks for submitting!

NOmoreFEARnz: Contact
bottom of page